[Federal Register Volume 67, Number 81 (Friday, April 26, 2002)]
[Notices]
[Page 20826]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-10301]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated October 2, 2001, and published in the Federal 
Register on October 11, 2001, (66 FR 51969), Dupont Pharmaceuticals, 
which has changed its name to Bristol-Myers Squibb Pharma Company, 1000 
Stewart Avenue, Garden City, New York 11530, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of the basic classes of controlled substances 
listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Oxycodone (9143)...........................  II
Hydrocodone (9193).........................  II
Oxymorphone (9652).........................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances to 
make finished products.
    DEA has considered the factors in Title 21, United States Code, 
Section 823(a) and determined that the registration of Bristol-Myers 
Squib Pharma Company to manufacture the listed controlled substances is 
consistent with the public interest at this time. DEA has investigated 
Bristol-Myers Squibb Pharma Company on a regular basis to ensure that 
the company's continued registration is consistent with the public 
interest. These investigations have included inspection and testing of 
the company's physical security systems, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 
0.100 and 0.104, the Deputy Assistant Administrator, Office of 
Diversion Control, hereby orders that the application submitted by the 
above firm for registration as a bulk manufacturer of the basic classes 
of controlled substances listed above is granted.

    Dated: April 11, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-10301 Filed 4-25-02; 8:45 am]
BILLING CODE 4410--09-M